EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 7 September 2023

News

EFPIA attends meeting to discuss opt-out requirements in EHDS
06 September 2023

An opt-out or opt-in mechanism with regard to the secondary use of electronic health data may lead to health data disparities.... Read more

Blogs

How the pharmaceutical industry is contributing to mitigate climate change
05 September 2023 - Nathalie Moll

New industry survey highlights commitments and ambitions of 23 global pharmaceutical companies Read more

Lung cancer: meeting patients’ needs through innovation
01 August 2023

An inclusive definition of unmet medical need is vital to driving better outcomes for patients Read more

New Film Highlights the Threat of AMR

The AMR Action Fund presents “Race Against Resistance: The Life and Death Struggle to Save Antibiotics,” a gripping film that takes viewers inside the world of patients affected by drug-resistant superbugs and highlights the work of clinicians, scientist, and advocates helping to advance new treatments and avert a global catastrophe.

Race Against Resistance: The Life And Death Struggle To Save Antibiotics

BBC StoryWorks

Unlocking the potential of new oncology treatments
12 September 2023 (Virtual event)

A cross-stakeholder discussion on improving the understanding, acceptance and use of oncology-relevant endpoints in... Read more

Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis...
26 September 2023 (Online)

Moving towards a new Alzheimer’s disease detection and diagnosis pathway Read more

Are medicines affordable for health systems?
29 September 2023 (Bad Hofgastein, Austria)

The myths, the facts, and the way forward Read more

EFGCP Better Medicines for Children Conference 2023
17 October 2023 (Amsterdam)

Global Paediatric Drug Development: the value of multi-stakeholders’ collaboration Read more

Delivering treatments to patients: The medicines manufacturing journey

Discover the intricate journey from molecule to medicine in our latest leaflet, "Delivering treatments to patients: The medicines manufacturing journey". Explore the world of pharmaceutical manufacturing and learn about EFPIA's commitment, from high quality to shortages prevention. Learn more and join us in spreading awareness about this crucial process.

What we are reading

America’s plan to cut drug prices comes with unpleasant side-effects
On 29 August 2023 (The Economist)

It is already changing how pharma companies make drugs.

Economic burden of cardiovascular diseases in the European Union: a population-based cost study...
On 26 August 2023 (European Heart Journal)

CVD impacts significantly health and social care systems as well as society through premature mortality and disability,... Read more

PFAS uncertainty: assessing risks and impacts on the pharmaceutical industry
On 18 August 2023 (PharmaLive)

Upcoming regulatory changes surrounding the use of perfluoroalkyl and polyfluoroalkyl substances (PFAS) have been... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu